☆Market information

• At the third plenary meeting of the first session of the 14th National People's Congress (NPC) on March 10, 2023, Xi Jinping was unanimously elected Chinese president at the ongoing session of China's national legislature.

He was also elected chairman of the Central Military Commission (CMC) of the People's Republic of China (PRC) by a unanimous vote.

Zhao Leji was elected chairman of the 14th NPC Standing Committee, Han Zheng as the Chinese vice president, and Wang Huning as chairman of the 14th CPPCC National Committee. Li Qiang was endorsed as the Chinese premier.

• API China 2023 will be held in Qingdao from April 12th to 14th.
• In 2023, Sinoway has fixed to attend below three exhibitions with separate booth：

Apr.19~21, CPhI Japan, Sinoway boot:6A-30
Jun. 19~21, CPhI Shanghai, Sinoway booth: E1A48
Oct.24-26, CPhI Worldwide(Barcelona), Sinoway booth:3G11

☆New Products Recommendation

This month, here we introduce a nice series product: Empagliflozin intermediates.

API : Empagliflozin, CAS No: 864070-44-0  ( *In the patent period, for R&D use only ) 

API Usage: For the treatment of diabetes.

Advantages:

1) We can provide API and its intermediates in every step in commercial scale with high quality.(Purity 99%up, Single impurity 0.1% below by HPLC or as your higher quality requirements）

2)Production capacity.(500kgs~10mt/month depending on different intermediates)

3)Can support customers to prepare technical documents for registration purpose.

4)The most regular intermediates supplied for your reference.

*Products can only be available in the area without patent issue.